it included mostly white participants and focused only on people with obesity
Australian company Zifam Pinnacle Pty Ltd, which markets Facia in Australia, and Contract Manufacturing & Packaging Services Pty Ltd (CMPS), which manufactures Facia products, are both featured on the packaging of the Facia Premium capsules for sale in Asia
Research also suggests benefits in reducing liver fat content in patients with non-alcoholic fatty liver disease/metabolic dysfunction-associated steatohepatitis (MASH), though these are not currently approved indications and represent areas of ongoing research
My core philosophy is to move beyond trends and instead rely on data
Short Takes Taken from C-SPAN's gavel-to-gavel coverage and condensed down to the key moments
BOOSTING ADHERENCE TO REDUCE GLP-1 WASTAGE We help members face and overcome the challenges that come with adhering to GLP-1 therapy, allowing them to maximize its benefits and reduce the financial waste of early discontinuation